About
Mathyn Adrianus Marinus Vervaart is a Researcher at the Department of Health Management and Health Economics, Faculty of Medicine, University of Oslo. His work bridges statistical modeling and health economic evaluation, with a focus on supporting decision-making under uncertainty in early access to new health technologies.
- Current Affiliation: Department of Health Management and Health Economics, University of Oslo
- Visiting Researcher: School of Health and Related Research (ScHARR), University of Sheffield (2020)
- Previous Role: Health Economist at the Norwegian Medicines Agency (2017)
- Research Assistant at University of Oslo (2015–2017)
His academic background includes a PhD in Health Economic Evaluation from the University of Oslo and MSc & MPhil degrees in the same field from Erasmus University Rotterdam and the University of Oslo.
- PhD in Health Economic Evaluation, University of Oslo
- MSc & MPhil in Health Economic Evaluation, Erasmus University Rotterdam / University of Oslo
Vervaart’s research focuses on advanced quantitative methods in health economics. He specializes in uncertainty quantification using value of information methods and survival analysis within health economic decision models. His work enables more informed decisions about the adoption of new medical technologies when evidence is limited, particularly in personalized medicine contexts.
The recent publications (2021–2024) demonstrate a consistent trajectory in developing computational methods for expected value of sample information (EVSI) in survival data settings. These works contribute both methodological innovations and practical tutorials, enhancing accessibility and reproducibility in the field of medical decision making.
He was awarded the Stephen Pauker Award in 2020 for outstanding presentations in quantitative methods at the Society for Medical Decision Making Annual Meeting.
- Stephen Pauker Award (2020) – SMDM North American Meeting
Vervaart is actively involved in research projects such as PRECISE, which aims to develop a health economic approach for evaluating uncertain evidence in personalized medicine. He is also part of EXCEED – Norway’s Network for Economic Evaluation in Health, contributing to national and international collaboration in health technology assessment. While no formal grants are listed, his work appears to be embedded in structured research groups and collaborative networks. He has not advised any named students in the provided data.
He contributes to collaborative research groups including EXCEED – Network for Economic Evaluation in Norway and focuses on the economic evaluation of health technologies. His work supports policy-relevant modeling and decision frameworks for health systems.
